MLJ CONSULTANCY LLC stands out by offering specialized online consulting that combines deep expertise in HIPAA compliance with practical guidance on AI integration, cybersecurity, revenue cycle management, data analytics, and project management, all tailored specifically for the healthcare sector, with live multimodal trustworthy AI support.
On February 8, 2024, the landscape of substance use disorder (SUD) treatment underwent a major shift. The U.S. Department of Health & Human Services (HHS), along with the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Office for Civil Rights, announced a final rule that updates how SUD patient records are handled under 42 CFR Part 2. These changes aim to align confidentiality rules with HIPAA and HITECH standards, promoting treatment while maintain
The 42 CFR Part 2 Final Rule has prompted important discussions about confidentiality in substance use disorder (SUD) patient records. This rule touches many lives, impacting how patients receive care and how providers share information. In this post, we will explore the key changes made in the rule, what aspects remain steady, and what this means for the future.